Literature DB >> 9000320

Factor analysis of schizophrenic symptoms using the OPCRIT checklist.

A G Cardno1, L A Jones, K C Murphy, P Asherson, L C Scott, J Williams, M J Owen, P McGuffin.   

Abstract

Factor analysis was performed on OPCRIT checklist psychotic symptoms rated on 102 patients with DSM-III-R schizophrenia. An initial three-factor solution produced positive, negative, and disorganisation factors. However, application of the scree test suggested five substantive factors, with the positive factor dividing into three factors characterised, respectively, by paranoid symptoms, first rank delusions and first rank hallucinations.

Entities:  

Mesh：

Year:  1996        PMID： 9000320     DOI： 10.1016/s0920-9964(96)00060-6

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


  8 in total

1.  Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test.

Authors:  Barbara Langen; Rita Dost; Ute Egerland; Hans Stange; Norbert Hoefgen
Journal:  Psychopharmacology (Berl)       Date:  2011-11-16       Impact factor: 4.530

2.  Concordance between chart review and structured interview assessments of schizophrenic symptoms.

Authors:  Ayman H Fanous; Richard L Amdur; Francis A O'Neill; Dermot Walsh; Kenneth S Kendler
Journal:  Compr Psychiatry       Date:  2011-06-12       Impact factor: 3.735

3.  OPCRIT+: an electronic system for psychiatric diagnosis and data collection in clinical and research settings.

Authors:  James Rucker; Stuart Newman; Joanna Gray; Cerisse Gunasinghe; Matthew Broadbent; Philip Brittain; Martin Baggaley; Mike Denis; John Turp; Robert Stewart; Simon Lovestone; Gunter Schumann; Anne Farmer; Peter McGuffin
Journal:  Br J Psychiatry       Date:  2011-08       Impact factor: 9.319

4.  A data-driven investigation of relationships between bipolar psychotic symptoms and schizophrenia genome-wide significant genetic loci.

Authors:  Ganna Leonenko; Arianna Di Florio; Judith Allardyce; Liz Forty; Sarah Knott; Lisa Jones; Katherine Gordon-Smith; Michael J Owen; Ian Jones; James Walters; Nick Craddock; Michael C O'Donovan; Valentina Escott-Price
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-04-19       Impact factor: 3.568

5.  The meaning of momentary psychotic-like experiences in a non-clinical sample: A personality perspective.

Authors:  Goran Knežević; Ljiljana B Lazarević; Aleksandar Zorić
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.752

6.  Harnessing clinical psychiatric data with an electronic assessment tool (OPCRIT+): the utility of symptom dimensions.

Authors:  Philip James Brittain; Sarah Elizabeth Margaret Lobo; James Rucker; Myanthi Amarasinghe; Anantha Padmanabha Pillai Anilkumar; Martin Baggaley; Pallavi Banerjee; Jenny Bearn; Matthew Broadbent; Matthew Butler; Colin Donald Campbell; Anthony James Cleare; Luiz Dratcu; Sophia Frangou; Fiona Gaughran; Matthew Goldin; Annika Henke; Nikola Kern; Abdallah Krayem; Faiza Mufti; Ronan McIvor; Humphrey Needham-Bennett; Stuart Newman; Dele Olajide; David O'Flynn; Ranga Rao; Ijaz Ur Rehman; Gertrude Seneviratne; Daniel Stahl; Sajid Suleman; Janet Treasure; John Tully; David Veale; Robert Stewart; Peter McGuffin; Simon Lovestone; Matthew Hotopf; Gunter Schumann
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

7.  Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis?

Authors:  Judith Allardyce; Robin G McCreadie; Gary Morrison; Jim van Os
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-05-14       Impact factor: 4.328

8.  Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.

Authors:  Diego Quattrone; Marta Di Forti; Charlotte Gayer-Anderson; Laura Ferraro; Hannah E Jongsma; Giada Tripoli; Caterina La Cascia; Daniele La Barbera; Ilaria Tarricone; Domenico Berardi; Andrei Szöke; Celso Arango; Antonio Lasalvia; Andrea Tortelli; Pierre-Michel Llorca; Lieuwe de Haan; Eva Velthorst; Julio Bobes; Miguel Bernardo; Julio Sanjuán; Jose Luis Santos; Manuel Arrojo; Cristina Marta Del-Ben; Paulo Rossi Menezes; Jean-Paul Selten; Peter B Jones; James B Kirkbride; Alexander L Richards; Michael C O'Donovan; Pak C Sham; Evangelos Vassos; Bart Pf Rutten; Jim van Os; Craig Morgan; Cathryn M Lewis; Robin M Murray; Ulrich Reininghaus
Journal:  Psychol Med       Date:  2018-10-04       Impact factor: 7.723
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.